PLUS Therapeutics director exercises 922 RSUs
PLUS THERAPEUTICS, INC. director Kyle Guse exercised restricted stock units to acquire 922 shares of Common Stock at no cost.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
PLUS THERAPEUTICS, INC. director Kyle Guse exercised restricted stock units to acquire 922 shares of Common Stock at no cost. After the transaction, he directly holds 922 Common shares. A related RSU grant totaling 2,764 units remains outstanding and vests in four substantially equal quarterly installments beginning on July 1, 2026.
Insider Trade Summary
922 shares exercised/converted
Exercise
2 txns
Insider
Guse Kyle
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 922 | $0.00 | $0.00 |
| Exercise | Common Stock | 922 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 2,764 contracts (Direct);
Common Stock — 922 shares (Direct)
Footnotes (2)
- F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
- F2. Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026.
Key Figures
Common shares acquired: 922 shares
Exercise price: $0.00 per share
Common shares held after: 922 shares
+2 more
5 metrics
Common shares acquired
922 shares
Common Stock received from RSU exercise on July 1, 2026
Exercise price
$0.00 per share
Price for 922 Common shares issued from RSUs
Common shares held after
922 shares
Direct ownership following the reported transaction
RSUs outstanding
2,764 units
Restricted Stock Units remaining after the transaction
RSU vesting schedule
Four equal quarterly installments
Vesting begins on July 1, 2026
Key Terms
Restricted Stock Unit, derivative security, vests in four substantially equal quarterly installments
3 terms
Restricted Stock Unit financial
"Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vests in four substantially equal quarterly installments financial
"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PSTV director Kyle Guse report on this Form 4?
Kyle Guse reported exercising restricted stock units to acquire 922 shares of PLUS THERAPEUTICS Common Stock at a per-share price of $0.00. This transaction reflects the conversion of derivative RSU awards into directly held common shares as part of his equity compensation.
What happens to Kyle Guse’s remaining Restricted Stock Units in PSTV?
A restricted stock unit grant of 2,764 units remains outstanding for Kyle Guse. According to the disclosure, these RSUs vest in four substantially equal quarterly installments beginning on July 1, 2026, each unit representing a contingent right to receive one share of Common Stock.
What does the $0.00 exercise price mean for the PSTV RSU transaction?
The $0.00 exercise price indicates Kyle Guse did not pay cash to convert restricted stock units into 922 Common shares. RSUs typically settle into shares upon vesting based on service or performance conditions, functioning as equity compensation rather than a cash investment purchase.
Is this PLUS THERAPEUTICS (PSTV) Form 4 an open-market buy or sale?
This Form 4 does not report an open-market buy or sale. It records the exercise of restricted stock units, a derivative security, resulting in the issuance of 922 Common shares to Kyle Guse as equity compensation, without any reported market purchase or sale transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
